173 related articles for article (PubMed ID: 22208967)
1. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
[TBL] [Abstract][Full Text] [Related]
2. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
4. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
Lund KV; Simonsen TG; Hompland T; Kristensen GB; Rofstad EK
Radiother Oncol; 2015 Jun; 115(3):379-85. PubMed ID: 25998804
[TBL] [Abstract][Full Text] [Related]
5. Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction.
Huang Z; Yuh KA; Lo SS; Grecula JC; Sammet S; Sammet CL; Jia G; Knopp MV; Wu Q; Beauchamp NJ; Yuh WT; Wang R; Mayr NA
Magn Reson Imaging; 2014 Dec; 32(10):1198-205. PubMed ID: 25179141
[TBL] [Abstract][Full Text] [Related]
6. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
Yuh WT; Mayr NA; Jarjoura D; Wu D; Grecula JC; Lo SS; Edwards SM; Magnotta VA; Sammet S; Zhang H; Montebello JF; Fowler J; Knopp MV; Wang JZ
Invest Radiol; 2009 Jun; 44(6):343-50. PubMed ID: 19661844
[TBL] [Abstract][Full Text] [Related]
7. Temporal analysis of tumor heterogeneity and volume for cervical cancer treatment outcome prediction: preliminary evaluation.
Prescott JW; Zhang D; Wang JZ; Mayr NA; Yuh WT; Saltz J; Gurcan M
J Digit Imaging; 2010 Jun; 23(3):342-57. PubMed ID: 19172357
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
[No Abstract] [Full Text] [Related]
9. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.
Mayr NA; Yuh WT; Jajoura D; Wang JZ; Lo SS; Montebello JF; Porter K; Zhang D; McMeekin DS; Buatti JM
Cancer; 2010 Feb; 116(4):903-12. PubMed ID: 20052727
[TBL] [Abstract][Full Text] [Related]
10. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
11. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
[TBL] [Abstract][Full Text] [Related]
12. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.
Mayr NA; Wang JZ; Lo SS; Zhang D; Grecula JC; Lu L; Montebello JF; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):719-27. PubMed ID: 19632061
[TBL] [Abstract][Full Text] [Related]
13. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
[TBL] [Abstract][Full Text] [Related]
14. Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.
Huang Z; Mayr NA; Lo SS; Grecula JC; Wang JZ; Jia G; Yuh WT
J Cancer Sci Ther; 2012 Sep; 4(9):254-259. PubMed ID: 23638244
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Montebello JF; Grecula JC; Lo SS; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1513-21. PubMed ID: 19286329
[TBL] [Abstract][Full Text] [Related]
17. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
19. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
20. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
